Records containing: Metastatic Melanoma
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2012-07-30Phase I Study of TTC (Taxotere/Temodar/Cisplatin) in Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2012-06-26A Phase I/II Study of Dasatinib and Dacarbazine in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-06-15A Phase 0 Exploratory Microdosing Study of 6-18fluoro-N-[2-(Diethylamino)Ethyl]Pyridine-3-carboxamide (18F MEL050) Using PET/CT in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2012-04-19Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-MART-1 F5 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization
-
CLINICAL_TRIALS study record update · 2012-04-10Phase II Study of Metastatic Melanoma Using Lymphodepleting Conditioning Followed by Infusion of Anti-gp100:154-162 TCR-Gene Engineered Lymphocytes and ALVAC Virus Immunization
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2012-03-29Adoptive Cell Therapy Following Non-myeloablate Chemotherapy in Metastatic Melanoma Patients
-
CLINICAL_TRIALS study record update · 2011-10-12A Phase I Study Evaluating the Safety, Pharmacokinetics, Tissue Distribution, and Determination of Radiation Dosimetry for 131-I-MIP-1145
-
CLINICAL_TRIALS study record update · 2011-07-14An Open-Label Phase I Safety, Pharmacokinetic & Dosimetry Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-07-14A Multi-Center, Open-Label, Phase I, Dose-Escalation and Safety Study of 188Re-PTI-6D2 in Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-07-07A Phase II Study of High-Dose Allovectin-7® in Patients With Advanced Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2011-01-17Phase II Trial of Imatinib(Gleevec®) in Selected Patients With Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-08-23Dose Finding Phase 1 Study of the Treatment of Metastatic Melanoma With MPC-6827 in Combination With Temozolomide
-
CLINICAL_TRIALS study record update · 2010-05-26Phase II Study of Multiepitope Peptide Vaccination in Combination With Adjuvants GM-CSF and KLH in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2010-04-26Collection of Long-Term Outcome Data for Subjects Who Have Previously Participated in Selected Ipilimumab (MDX-010) Studies in Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2009-05-11A Phase 1/2, Multi-Center, Safety and Efficacy Study Evaluating Intravenously Administered 131I-TM601 in Patients With Progressive and/or Recurrent Malignant Melanoma
-
CLINICAL_TRIALS study record update · 2009-04-03Bevacizumab, Dacarbazine and Interferon Alfa-2a Combination as a First-Line Therapy in Patients With Locally Advancing or Metastatic Melanoma
-
CLINICAL_TRIALS study record update · 2006-06-21Standard Palliative Care Versus Standard Palliative Care Plus Polychemotherapy (CVD-Protocol) in the Second-Line Therapy of Distant Metastasized Malignant Melanoma